DexCom Correlations
DXCM Stock | USD 77.99 0.11 0.14% |
The current 90-days correlation between DexCom Inc and Insulet is 0.16 (i.e., Average diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as DexCom moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if DexCom Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
DexCom Correlation With Market
Significant diversification
The correlation between DexCom Inc and DJI is 0.08 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding DexCom Inc and DJI in the same portfolio, assuming nothing else is changed.
DexCom |
Moving together with DexCom Stock
0.69 | EW | Edwards Lifesciences Corp | PairCorr |
0.65 | GH | Guardant Health | PairCorr |
0.65 | LH | Laboratory | PairCorr |
0.66 | OM | Outset Medical | PairCorr |
0.74 | VREX | Varex Imaging Corp | PairCorr |
0.72 | ELMD | Electromed | PairCorr |
0.65 | BSX | Boston Scientific Corp Sell-off Trend | PairCorr |
0.74 | SYK | Stryker | PairCorr |
0.75 | LNSR | LENSAR Inc | PairCorr |
0.66 | NPCE | Neuropace | PairCorr |
0.63 | OFIX | Orthofix Medical | PairCorr |
0.61 | PODD | Insulet | PairCorr |
0.72 | TCMD | Tactile Systems Tech | PairCorr |
Moving against DexCom Stock
0.7 | EKSO | Ekso Bionics Holdings | PairCorr |
0.58 | DRIO | DarioHealth Corp | PairCorr |
0.55 | VERO | Venus Concept | PairCorr |
0.43 | CI | Cigna Corp | PairCorr |
0.55 | LIFWW | MSP Recovery | PairCorr |
0.42 | MDT | Medtronic PLC | PairCorr |
0.37 | KIDS | Orthopediatrics Corp | PairCorr |
0.33 | CVS | CVS Health Corp Sell-off Trend | PairCorr |
0.82 | ME | 23Andme Holding Upward Rally | PairCorr |
0.71 | TNDM | Tandem Diabetes Care | PairCorr |
0.71 | A | Agilent Technologies Sell-off Trend | PairCorr |
0.63 | VALN | Valneva SE ADR | PairCorr |
0.47 | DNLI | Denali Therapeutics | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between DexCom Stock performing well and DexCom Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze DexCom's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
TNDM | 2.40 | (0.68) | 0.00 | (0.43) | 0.00 | 4.24 | 12.63 | |||
INSP | 2.23 | (0.10) | (0.01) | 0.07 | 2.67 | 5.61 | 16.85 | |||
SWAV | 1.68 | 0.09 | (0.03) | (0.21) | 2.04 | 3.76 | 16.22 | |||
PEN | 1.67 | 0.28 | 0.10 | 1.24 | 1.82 | 4.55 | 11.17 | |||
PODD | 1.12 | 0.37 | 0.26 | 1.53 | 0.64 | 2.87 | 12.33 | |||
IART | 2.27 | 0.22 | 0.08 | 0.36 | 2.26 | 3.54 | 31.15 | |||
SENS | 3.24 | (0.27) | 0.00 | (0.21) | 0.00 | 6.67 | 26.13 | |||
EW | 1.17 | 0.04 | (0.04) | 0.31 | 1.45 | 2.42 | 8.56 | |||
INMD | 2.12 | 0.10 | 0.08 | 0.18 | 2.71 | 4.56 | 17.38 |
DexCom Corporate Management
Shelly Selvaraj | Senior Officer | Profile | |
Leverne Marsh | Executive Marketing | Profile | |
Matthew Dolan | Corporate Strategy | Profile | |
Teri Lawver | Executive Officer | Profile | |
Donald Abbey | Quality Services | Profile | |
Jereme Sylvain | CFO VP | Profile |